BUCCI, Marco
 Distribuzione geografica
Continente #
EU - Europa 4.451
NA - Nord America 3.843
AS - Asia 2.090
SA - Sud America 141
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 4
Totale 10.556
Nazione #
US - Stati Uniti d'America 3.810
IT - Italia 1.271
SG - Singapore 864
CN - Cina 658
IE - Irlanda 580
UA - Ucraina 480
SE - Svezia 478
DE - Germania 461
FR - Francia 426
TR - Turchia 330
GB - Regno Unito 314
FI - Finlandia 189
IN - India 145
BR - Brasile 127
RU - Federazione Russa 92
HK - Hong Kong 30
BE - Belgio 25
CA - Canada 22
NL - Olanda 22
PL - Polonia 21
AT - Austria 13
ES - Italia 12
CH - Svizzera 10
IR - Iran 10
CZ - Repubblica Ceca 9
EG - Egitto 9
GR - Grecia 9
EU - Europa 8
IL - Israele 8
MX - Messico 8
BD - Bangladesh 7
LT - Lituania 7
VN - Vietnam 6
AR - Argentina 5
EC - Ecuador 5
ID - Indonesia 5
MY - Malesia 5
SI - Slovenia 5
EE - Estonia 4
JP - Giappone 4
PT - Portogallo 4
AL - Albania 3
AU - Australia 3
PK - Pakistan 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
UZ - Uzbekistan 3
ZA - Sudafrica 3
DK - Danimarca 2
IQ - Iraq 2
KR - Corea 2
KZ - Kazakistan 2
LV - Lettonia 2
NO - Norvegia 2
PY - Paraguay 2
RO - Romania 2
TH - Thailandia 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
BG - Bulgaria 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
GT - Guatemala 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
MC - Monaco 1
NZ - Nuova Zelanda 1
PA - Panama 1
RS - Serbia 1
SC - Seychelles 1
SN - Senegal 1
Totale 10.556
Città #
Chandler 720
Singapore 572
Jacksonville 566
Dublin 561
Princeton 254
Munich 242
Southend 222
Izmir 197
The Dalles 163
Nanjing 157
Ashburn 146
Beijing 132
Ann Arbor 119
Wilmington 110
Pescara 107
Helsinki 102
Dearborn 97
Santa Clara 97
Cambridge 92
Chieti 91
New York 91
Milan 73
Boardman 69
Los Angeles 63
Nanchang 63
Altamura 62
Rome 45
Woodbridge 40
Shenyang 35
Hebei 31
Foggia 30
Tianjin 30
Houston 28
Washington 28
Brussels 24
Nuremberg 23
Hong Kong 21
Jinan 21
Kunming 19
Norwalk 17
Bologna 15
Zhengzhou 15
Florence 14
Grevenbroich 14
Hangzhou 14
Ningbo 13
Auburn Hills 12
Changsha 12
Jiaxing 12
London 12
Orange 12
São Paulo 12
Guangzhou 11
Toronto 11
Brooklyn 10
Kraków 10
San Mateo 10
Taizhou 10
Frankfurt am Main 9
Moscow 9
Seattle 9
Bari 8
Brno 8
Lanzhou 8
Mountain View 8
Palermo 8
San Francisco 8
Amsterdam 7
Avellino 7
Catania 7
Changchun 7
Padova 7
Rio de Janeiro 7
Spoltore 7
Andover 6
Augusta 6
Brescia 6
Campobasso 6
Catanzaro 6
Falls Church 6
Naples 6
Nocera Inferiore 6
Simi Valley 6
Chicago 5
Dong Ket 5
Grugliasco 5
Hefei 5
Jyväskylä 5
Legnano 5
Mexico City 5
Napoli 5
Sala Baganza 5
San Vito Chietino 5
Shanghai 5
Stockholm 5
Turin 5
Warsaw 5
Athens 4
Carini 4
Council Bluffs 4
Totale 6.039
Nome #
Indici di rigidità arteriosa e rischio cardiovascolare globale: risultati da una popolazione abruzzese in prevenzione primaria 488
Rosuvastatin reduces Matrix Metalloproteinase (MMP)-9 and Plasminogen Activator Inhibitor (PAI)-1 expression via a microRNA-dependent pathway 211
Comparison between Dutch Lipid Clinic Network (DLCN) criteria, Simon Broome register group (SB) and US MedPed Program diagnostic performance in a pediatric cohort from LIPIGEN study population: preliminary data. 186
MicroRNA profiling in migraine without aura: Pilot study 186
VALUTAZIONE FUNZIONALE DELL'ATLETA: RAPPORTI TRA VO2 MAX E COMPOSIZIONE CORPOREA 141
(Dis)-agreement among Cardiovascular Risk Calculators in clinical practice 134
The diagnostic performance of the Italian Society for the Study of Atherosclerosis (SISA)-modified Dutch Lipid Clinic Network (DLCN) criteria in a pediatric cohort from LIPIGEN study population: preliminary data 130
Uneven accuracy of home blood pressure measurement: a multi-centric survey 129
Linee guida cliniche per la prevenzione della cardiopatia ischemica nella ipercolesterolemia familiare: una patologia sotto-diagnosticata e sotto-trattata. Consensus. 121
Long-term Positivity to SARS-CoV-2: A Clinical Case of COVID-19 with Persistent Evidence of Infection 117
Differences in blood pressure according to body position (supine, Fowler’s and sitting) in hypertensive subjects 115
A short-term vs a long-term infusion plan. A 20-week, European randomized trial. Analysis of efficacy and costs. 114
A unique microRNA signature associated with plaque instability in humans. 112
OVEREXPRESSION OF TOLL LIKE RECEPTOR 4 AS A BASIS OF CYCLOOXYGENASE 2-DEPENDENT ATHEROSCLEROTIC PLAQUE INSTABILITY IN HUMANS. 111
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 111
Risultati immediati ed a lungo termine della rivascolarizzazione coronarica con PTCA con carattere ad autoperfusione vs PTCA con impianto di stent intracoronarico. 109
Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteases activity 109
A unique microRNA signature associated with ischemic stroke in humans 108
[Controllo dei fattori di rischio cardiovascolare nella comune pratica clinica in un campione di pazienti in prevenzione secondaria rappresentativo della popolazione abruzzese] 107
Pressure and microcirculatory effects of treatment with lercanidipine in hypertensive patients and in vascular patients with hypertension 105
Total triterpenic fraction of Centella asiatica in chronic venous insufficiency and in high-perfusion microangiopathy. 102
Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. 102
Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients 100
MicroRNA profiling reveals new potential modulators of insulin-resistance and cardiovascular risk in type 2 diabetes 100
Bioequivalence study of two tablet formulations of ramipril in healthy volunteers 99
ATP-binding cassette transporter A1 (ABCA1) overexpression in hypercholesterolemic plaques: a potential molecular explanation 98
Association between 5-lipoxygenase expression and plaque instability in humans. 98
PGE(1) treatment of severe intermittent claudication (short-term versus long-term, associated with exercise)--efficacy and costs in a 20-week, randomized trial 97
Evaluation of treatment of diabetic microangiopathy with total triterpenic fraction of Centella Asiatica: a clinical prospective randomized trial with a microcirculatory model. 95
Efficacy of a nurse-led email reminder program for cardiovascular prevention risk reduction in hypertensive patients: a randomized controlled trial. 95
Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control 95
Ipertensione arteriosa ed algosensibilità muscolare 94
PROGETTO DI SCREENING SU 24.000 SOGGETTI IN ETA' SCOLARE DELL'OBBLIGO DELLA PROVINCIA DI PESCARA. DATI PRELIMINARI. 94
LDL-Apheresis abruzzo network: an old-new opportunity for the management of patients at high cardiovascular risk. 92
A case of coinfection with SARS-COV-2 and Cytomegalovirus in the Era of Covid-19 92
Single coronary artery with a right origin: angiography identification of the R-II subgroup] 91
La gestione del profilo lipidico nei pazienti in prevenzione secondaria sul territorio: lo studio ELL 91
uFollow-Up clinico di un gruppo di pazienti sottoposti a PTCA con impianto di stent intracoronarico. 90
Reduced TIA-1 expression in vulnerable atherosclerotic plaques as a basis of cyclooxygenase-2-dependent plaque instability in humans. 90
L’automisurazione domiciliare della pressione: istruzioni per l’uso e sua utilità nel paziente anziano 90
High dose rosuvastatin increases ABCA1 transporter in human atherosclerotic plaques in a cholesterol-independent fashion 90
Overexpression of ABCA1 in human plaques exposed to hypercholesterolemia: the role of microRNA modulation 89
Ensuring Longer Life Study. A new model for an integrated management of patients at high cardiovascular risk. 88
MicroRNA profiling reveals new potential modulators of insulin-resistance in type 2 Diabetes 88
Total triterpenic fraction of Centella asiatica in the treatment of venous hypertension: a clinical, prospective, randomized trial using a combined microcirculatory model. 87
Hypertension is a determinant of ABCA1 expression in atherosclerotic plaques from hypercholesterolemic patients 87
ABCA-1 expression is reduced in atherosclerotic plaques from hypertensive patients: a new potential link between hypertension and atherosclerosis 86
ABCA-1 Expression is reduced in atherosclerotic plaques of hypertensive patient: a new link between hypertension and atherosclerosis 86
HUR protein contributes to modulation of angiotensin ii type 1 receptor expression in human atherosclerotic plaque. 85
[European trial of PGE1 alpha cyclodextrin. Short-term vs. long-term therapy in intermittent claudication] 85
MicroRNA profiling reveals new potetial modulators of insulin resistance and cardiovascular risk in type 2 diabetes 85
Effect of Rosuvastatin on MicroRNAs expression in human atherosclerotic plaques: results from Quasar Study 85
The (K+)ey of the problem 85
From Endothelium to Lipids, Through microRNAs and PCSK9: A Fascinating Travel Across Atherosclerosis 84
Angiotensin II Blockade and Total Cardiovascular Risk. Beyond Blood Pressure Reduction. 83
Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids 83
Nomograms used to define the short-term treatment with PGE(1) in patients with intermittent claudication and critical ischemia. The ORACL.E (Occlusion Revascularization in the Atherosclerotic Critical Limb) Study Group. The European Study. 82
Arterial stiffness and global cardiovascular risk: results from a primary prevention population from Abruzzo (Italy) 82
Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes 82
Possible indication of coronary risk trough discriminant functions. 81
Treatment of Diabetic Microangiopathy and Edema with Total Triterpenic Fraction of Centella Asiatica: A Prospective, Placebo-Controlled Randomized Study. 80
DISAGREEMENT AMONG THE MAIN ALGORITHMS FOR CARDIOVASCULAR RISK ESTIMATION IN PATIENTS STRATIFICATION AND IN THEIR CORRELATION WITH ARTERIAL STIFFNESS 80
Artrite reumatoide ed aumentato rischio cardiovascolare: impatto delle differenti terapie farmacologiche
 [Rheumatoid arthritis and increased cardiovascular risk: role of the different pharmacological therapies] 80
Improvement of Inflammation and Pain after Three Months’ Exclusion Diet in Rheumatoid Arthritis Patients 80
HuR protein as potential modulator of angiotensin II type 1 receptor expression in human atherosclerotic plaque. 79
24-months follow-up to assess the efficacy and tolerability of evolocumab in a young patient with chronic and progressive ischemic arteriopathy 79
Microcirculatory Effects of Total Triterpenic Fraction of Cenetlla asiatica in Chronic Venous Hypertension: Measurement by Laser Doppler, TcPo2-CO2, and Leg Volumetry 78
La stratificazione del rischio di sviluppare Diabete Mellito come strumento di diagnosi precoce: lo studio DIGA 77
PROGETTO DI SCREENING SU 24OOO SOGGETTI IN ETA' SCOLARE DELL'OBBLIGO DELLA PROVINCIA DI PESCARA. DATI PRELIMINARI 77
[ANALYSIS OF COSTS AND RESULTS OF PROSTAGLANDIN (PGE1 ALPHA-CYCLODESTRIN) THERAPY OF PERIPHERAL ARTERIAL DISEASES] 77
Increase in Echogenicity of Echolucent Carotid Plaques After Treatment with Total Triterpenic Fraction of Centella Asiatica: A Prospective, Placebo-Controlled, Randomized Trial. 76
Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10 year follow-up study (the CAFES-CAVE Study). 75
COVID-19 and RAS: Unravelling an Unclear Relationship 75
Oxygen-free radical decrease in hypertensive patients treated with lercanidipine 74
Cost-effectiveness of statins in primary and secondary prevention of cardiovascular event 74
Cardiovascular risk factor control in common clinical practice in a sample of patients in secondary prevention representative of the Abruzzo population 74
Treatment of long-distance intermittent claudication with pentoxifylline: a 12-month, randomized trial. 73
HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides) in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trial. 73
Hypertension modulates miR-145 expression in human atherosclerotic plaques 73
Impact of hypertension on somatic pain sensitivity in chronic headache 73
[Reduction of cardiovascular morbidity/mortality in arteriopathies treated ith PGE1 alpha-cyclodextrin] 72
Muscle pain sensitivity in hypertensive patients with and without chronic pain 72
null 71
Cyclooxygenase and prostaglandin synthases in atherosclerosis: Recent insights and future perspectives 71
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 70
Correlation between Dutch lipid score and genetic diagnosis of FH in pediatric patients 70
Plasma microRNA signature associated with retinopathy in patients with type 2 diabetes 70
Lp(a) and cardiovascular risk: Investigating the hidden side of the moon 69
A case of coinfection with SARS-Cov-2 and cytomegalovirus in the era of Covid-19. 69
Subcutaneous adipose tissue elastosonography in obese patients: a preliminary report 69
Effects of Rosuvastatin on the expression of microRNAs and their putative targets in human atherosclerotic plaques: the QUASAR Study 67
Treatment of intermittent claudication with pentoxifylline: A 12-month, randomized trial: Walking distance and microcirculation 66
LA MALATTIA DI BARLOW NELLO SPORTIVO: TECNICA CHIRURGICA INNOVATIVA 63
Effects of the total triterpenic fraction of Centella asiatica in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trial 63
Effects of lifestyle treatment on patients with metabolic syndrome and non-alcoholic hepatic steatosis evaluated with an ultrasonographic and elastographic approach 63
When a timely diagnosis means life: a precious lesson from a clinical case 63
null 63
Microcirculatory effects of total triterpenic fraction of Centella asiatica in chronic venous hypertension: measurement by laser Doppler, TcPO2-CO2, and leg volumetry. 62
Cardiovascular morbidity/mortality modified by the use of FGE1 alpha-cyclodextran and calcium heparin in patients with severe vascular diseases 62
The fascinating relationship between liver stiffness and cholesterol 62
Totale 9.416
Categoria #
all - tutte 45.661
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.661


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202061 0 0 0 0 0 0 0 0 0 0 0 61
2020/2021829 116 15 118 36 64 149 35 38 82 90 36 50
2021/2022744 34 20 22 153 39 14 28 39 62 29 122 182
2022/20232.129 165 256 119 223 214 414 130 159 274 44 70 61
2023/20241.188 82 44 75 40 85 333 225 44 35 64 25 136
2024/20252.501 133 449 356 74 103 144 217 159 356 145 302 63
Totale 11.044